Chronic Prostatitis / Male Chronic Pelvic Pain Syndrome
Chronic prostatitis type III — also called chronic pelvic pain syndrome (CPPS or CP/CPPS) — is the most common form of prostatitis, accounting for 90–95% of all cases. Unlike acute bacterial prostatitis (type I) or chronic bacterial prostatitis (type II), CP/CPPS has no identifiable infectious agent: it is a chronic pelvic pain syndrome with a major neural sensitization component. It affects 8–10% of adult men, with a peak between 30–50 years of age, and an impact on quality of life comparable to that of myocardial infarction and Crohn's disease.
CP/CPPS symptoms are varied: pelvic pain (suprapubic, perineal, testicular, penile, lumbar); urinary symptoms (urgency, frequency, dysuria, hesitancy); and sexual symptoms (painful ejaculation, psychogenic erectile dysfunction, reduced libido). Painful ejaculation is often the most disabling symptom and the most responsive to acupuncture.
Conventional Treatments: Modest Results
Treatment of CP/CPPS is challenging: no single therapy is universally effective. The multimodal approach ("UPOINT") — which classifies symptoms into domains and treats them individually — is the currently most accepted paradigm.
TREATMENTS FOR CP/CPPS
| TREATMENT | EFFICACY ON NIH-CPSI | LIMITATIONS |
|---|---|---|
| Alpha-blockers (tamsulosin 0.4 mg) | NIH-CPSI −4 to −6 pts; mainly urinary improvement | Orthostatic hypotension, reflex tachycardia, retrograde ejaculation; modest efficacy on pain |
| Antibiotics (fluoroquinolones 4–6 weeks) | Response in 40–50% (especially type IIIa) | Type IIIa only; little use in type IIIb; bacterial resistance; GI effects |
| NSAIDs | Moderate symptomatic relief; does not modify the disease | Chronic use: GI and renal risk; ineffective alone |
| Finasteride (for associated BPH) | Improvement of urinary symptoms in men with enlarged prostate | Erectile dysfunction, reduced libido, abnormal ejaculation |
| Psychotherapy / CBT for pain | Effective for catastrophizing and central component | Limited access; does not address peripheral or urinary component |
| Acupuncture | NIH-CPSI −8.4 pts in a controlled study (Eur Urol 2018); in head-to-head comparisons, results similar to alpha-blockers — does not replace pharmacotherapy when indicated | Access and cost; requires 8–12 sessions; moderate-quality and heterogeneous evidence |
How Acupuncture Works in Chronic Prostatitis
Mechanisms in CP/CPPS
Neuromodulation of Sacral Roots (S2–S4)
BL-32+BL-33 (sacral foramina) and CV-3 modulate the S2–S4 roots that innervate the prostate, bladder, and perineum via the pelvic and pudendal nerves. EA at 2 Hz reduces hypersensitized prostatic and perineal afferent discharge, breaking the pain-spasm-pain cycle.
Reduction of Prostatic Mast Cell Activation
ST-36 and LI-11 inhibit mast cell degranulation in the prostatic interstitium — mast cells are the main inflammatory mediators in type IIIa CP/CPPS. Studies on prostatic biopsy in men treated with acupuncture show reduced mast cell density and lower NGF levels in prostatic fluid.
Relief of Pelvic Floor Spasm
Pelvic floor muscle spasm (levator ani, pubococcygeus, ischiocavernosus) contributes to perineal and prostatic pain in CP/CPPS. SP-6 and BL-36 reflexively inhibit these muscles via the spino-bulbo-spinal pathway — reducing perineal pressure and painful ejaculation.
LR-3 and KI-3 — Traditional Context and Neural Correlate
In the tradition of Chinese medicine, the prostate is described as part of the Kidney and Liver channels. Biomedically, LR-3 (Taichong) lies over the deep peroneal nerve and KI-3 (Taixi) close to the posterior tibial bundle (L4–S1); both converge with pelvic afferents at the spinal level, possibly modulating prostatic pain perception via descending pathways — evidence still preliminary in CP/CPPS.
Main Points
BL32–BL33 + CV3 — Central Pelvic Neuromodulation
Fundamental trio in CP/CPPS treatment: sacral foramina for the pelvic and pudendal nerves; CV3 as the Front-Mu point of the bladder and a point of pelvic convergence. EA at 2 Hz on this set reaches the sacral reflex arc that perpetuates chronic pelvic pain.
SP6 + LR3 — Perineal Antispasm
SP6 inhibits the hypertonic pelvic floor via the tibio-spinal reflex; LR3 mobilizes stagnant Qi in the hepatic-pelvic region. Particularly effective for painful ejaculation and testicular pain — symptoms that often persist with alpha-blockers.
ST36 — Prostatic Anti-inflammatory
ST36 activates the cholinergic anti-inflammatory reflex via the vagus nerve, reducing prostatic mast cells and NGF. Essential complement to the local protocol for the inflammatory component of type IIIa CP/CPPS.
KI3 — Sexual and Renal-Prostatic Function
KI3 governs sexual energy and urination in TCM. Neurobiologically: activates the medial saphenous nerve, converging at the S1–S3 level with afferents from the pudendal nerve. Improves erectile dysfunction associated with the anxious and autonomic component of CP/CPPS.
Scientific Evidence
Modern Approach: Integration into the UPOINT Model
The UPOINT model (Urinary, Psychosocial, Organ-specific, Infection, Neurological, Tenderness) is the currently most accepted paradigm for CP/CPPS. Acupuncture addresses multiple domains simultaneously: urinary (sacral neuromodulation), organ-specific (prostatic anti-inflammatory), neurological (central sensitization), and muscular (pelvic floor spasm).
When to See a Medical Acupuncturist
Indications
Type IIIb CP/CPPS (non-inflammatory) confirmed by a urologist; failure or intolerance to alpha-blockers; prominent painful ejaculation; sexually active young man who declines retrograde ejaculation from alpha-blockers; hypertonic pelvic floor component.
Diagnosis First
Acute prostatitis (fever + dysuria) is a medical emergency — not an indication for acupuncture. The diagnosis of CP/CPPS requires exclusion of bacterial prostatitis, BPH, and malignancy. Always start with urological evaluation.
Frequently Asked Questions
Frequently Asked Questions
No. Acute bacterial prostatitis (type I) and chronic bacterial prostatitis (type II) require antibiotic therapy — it is the definitive treatment and cannot be replaced. Acupuncture can be used as a complement for pain control and urinary symptoms after antibiotic initiation, but never as a substitute. The main indication for acupuncture is type III CP/CPPS (without an identifiable bacterium).
Most studies show measurable improvement starting after 4–6 weekly sessions. The full response (NIH-CPSI −8 pts) consolidates over 8–12 weeks. Painful ejaculation tends to improve more rapidly (4–6 weeks); urinary symptoms generally take longer. After the active phase, monthly maintenance sessions sustain the benefit.
Yes — they are compatible. Many patients begin acupuncture while still using the alpha-blocker, and progressively reduce the dose as the response to acupuncture consolidates. The decision to taper the alpha-blocker should be gradual and guided by the physician, since abrupt withdrawal may cause temporary worsening of urinary symptoms.
Yes, especially when the erectile dysfunction has a psychogenic and autonomic component — which is frequent in CP/CPPS. Chronic pelvic pain, related anxiety, and pelvic floor hypertonicity contribute to ED. Acupuncture (KI-3, LR-3, SP-6, PC-6) addresses these mechanisms. ED with a predominantly organic component (atherosclerosis, diabetic neuropathy) requires specific urological evaluation.